Erin McEvoy

As bat guano becomes more commonly used in cannabis cultivation, a recent study highlights the negative effects that can come with using this type of fertilizer.

With the recent 2024 presidential election behind us, the future of cannabis still has many unknowns moving forward and questions still to be discussed. In this roundtable discussion with four knowledgeable industry leaders, we explore the nuanced political landscape of cannabis legalization and rescheduling in the context of the election, including state and federal policies and possible paths forward for testing standardization. Join us in the second part of a compilation of responses from Kim Anzarut, CQA, CP-FS, CEO of Allay Consulting; Susan Audino, PhD, founder of S.A. Audino & Associates, LLC; Zacariah Hildenbrand, PhD, research Professor at the University of Texas at El Paso; and David Vaillencourt, CEO of The GMP Collective.

With the recent 2024 presidential election behind us, the future of cannabis still has many unknowns moving forward and questions still to be discussed. In this roundtable discussion with four knowledgeable industry leaders, we explore the nuanced political landscape of cannabis legalization and rescheduling in the context of the election. We discuss what drives support or opposition from both sides of the aisle, the complexities of balancing state and federal priorities, and more. Join us in the first part of a compilation of responses from Kim Anzarut, CQA, CP-FS, CEO of Allay Consulting; Susan Audino, PhD, founder of S.A. Audino & Associates, LLC; Zacariah Hildenbrand, PhD, research Professor at the University of Texas at El Paso; and David Vaillencourt, CEO of The GMP Collective.

The December webinar from Healer featured several studies on various conditions treated with medical cannabis.

Founder of S. A. Audino & Associates, LLC, Susan Audino, PhD, recently co-founded Saturn Scientific, LLC, a collaboration of five experienced individuals providing unbiased evaluations on the data and science for stakeholders in the cannabis industry. In this interview with Cannabis Science and Technology, Dr. Audino shares her unexpected path into analytical science and the cannabis industry as well as the obstacles she’s faced throughout her career. She highlights the gender bias she’s observed, such as unequal recognition of credentials and workplace challenges, while advocating for inclusivity and mentorship to empower women in science. Additionally, Dr. Audino recounts her experiences of navigating the male-dominated cannabis space, pushing for transparency, collaboration, and integrity in laboratory practices. Ultimately, Audino believes fostering mutual respect and knowledge-sharing is vital for the industry’s growth and resilience.

In this interview with Cannabis Science and Technology, Julie Kowalski, an experienced analytical chemist, discusses her path into the cannabis industry, starting with early work in gas chromatography. Kowalski reflects on her perspectives as a female scientist, highlighting biases she’s experienced and the benefits of gender inclusivity in the cannabis space. Greater unity and professionalism could benefit the industry as a whole, she explains. She also encourages collaboration and more women in leadership positions in order to build a stronger scientific community, and also urges women to advocate for themselves, noting that women in cannabis face unique obstacles but often demonstrate consensus-building strategies and solutions.

A study involving older adults revealed correlation between CBD use and health issues.

The study aimed to evaluate short-term, repeated use of low dose CBD and intense exercise.

Researchers examined a half-dozen medical records involving CBD used to treat THC toxicosis in dogs.

A recent review explored the connection between ADHD symptoms, cannabis use, the ECS, and potential therapeutic effects.

Accredited by A2LA, the scope of accreditation to ISO/IEC 17043 now includes six cannabis and hemp oil proficiency testing programs.

The recently passed amendment deprioritized cannabis enforcement in Dallas, Texas.

This month’s GMP Collective webinar focused on how collaboration within the industry can lead to overall growth and success.

A recent study explored cannabis use and age-related cognitive decline in men, taking into account first use of cannabis and usage frequency.

A New Zealand study aimed to assess cannabis use as a harm reduction tool. Findings highlight lifestyle factors, and suggest cannabis-focused harm reduction strategies in reducing other substance use such as alcohol.

This month’s webinar covered recent studies on cannabis use during pregnancy, CBD and anxiety, cannabis tea, and more.

The hemp products were seized from the ABC licensed locations for being out compliance with the state's new regulations.

Several surveys from 2024 reveal data and characteristics of adult American cannabis usage and opinions.

On November 5, 2024, Floridians will decide on Amendment 3, which proposes legalizing recreational cannabis. Former President Trump has stated support for this measure, aligning with his stance on state-level cannabis policies.

Listen to a Noid Factoid from Susan Audino, PhD, founder of S.A. Audino & Associates, LLC, and co-founder of Saturn Scientific, LLC.

This interview discusses the challenges in conducting unbiased research on the benefits of minor cannabinoids for pets, the potential synergistic effects of terpenes, and emerging research on using cannabinoid blends to treat conditions like epilepsy in dogs.

This month’s webinar covered research on cannabis studied as a treatment for rheumatic disorders, menstrual symptoms, eczema, and more.

The new hemp regulations, limiting THC levels in products, took effect in September.

Our sister publication, Nutritional Outlook, covered the current regulatory landscape for hemp as a supplement and how the 2024 Farm Bill could change things in the near future.

MM411’s president and co-founder, Chris DeVol, discusses challenges and trends in global cannabis education, plus upcoming initiatives of the company.

MM411’s president and co-founder, Chris DeVol, discusses the evolution of the company, their most popular cannabis education courses, and their partnership with Cannabis Science and Technology.

The ruling states that federal law does not block the ban on certain cannabinoid products in the state.

Researchers shared their latest research on the fungus that is a threat to seeds and crops across the nation.

This report is the first one published since the state’s legal market began.

Overall, the survey revealed that people with chronic pain supported policies expanding medical cannabis access more than physicians.